Position in PVLA
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$6,567,439
+$1,401,320 QoQ
Shares Held
42,975
+3.7% QoQ
Ownership
0.298%
of shares outstanding
% of Portfolio
1.47%
of 13F equity value
Holder Rank
#47
of 197 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PVLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Lisanti Capital Growth, LLC holds $52,162,640 across 8 Biotechnology names. PVLA ranks #5 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
91,610 | $7,965,489 | |
| 2 | MIRM |
Mirum Pharmaceuticals, Inc.
|
63,295 | $7,409,945 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
19,050 | $7,080,313 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
119,005 | $6,760,674 | |
| 5 | PVLA |
Palvella Therapeutics, Inc.
This page
|
42,975 | $6,567,439 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
18,747 | $5,925,739 | |
| 7 | VCEL |
Vericel Corp
|
120,380 | $5,355,706 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
20,825 | $5,097,335 |
All Filings in PVLA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,567,439 | 42,975 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $5,166,119 | 41,445 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $4,340,664 | 41,470 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||